Tate & Lyle PLC

TATE

Equity

ISIN GB00BP92CJ43 / Valor 118200687

LSE London Stock Exchange, SETS (2025-11-19)

GBP 3.86+1.96%

Tate & Lyle PLC
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Tate & Lyle PLC is a global provider of ingredients and solutions to the food, beverage, and other industries, specializing in sweeteners, starches, and nutritional ingredients.

Summarized from source with an LLMView SourceSector: Consumer Non-Cyclicals

Robust Performance

Excluding CP Kelco, Tate & Lyle achieved a 4% increase in EBITDA, with the EBITDA margin expanding by 200 basis points. Revenue grew by 5%, driven by strong volume growth and effective cost management.

Successful CP Kelco Integration

The acquisition of CP Kelco has exceeded expectations, delivering a 9% increase in EBITDA and enhancing the combined company's margin by 100 basis points. Pro forma EBITDA for the enlarged Tate & Lyle rose by 5%, reflecting the synergistic benefits of the merger.

Accelerating Innovation

New product revenues surged by 9% on a like-for-like basis, fueled by increased demand for fiber-enhanced products. Additionally, new business wins in solutions accounted for 21% of the pipeline value, underscoring the company’s commitment to innovation.

Excellent Cash Generation

The company reported a free cash flow of £190 million, including contributions from CP Kelco, marking a £20 million increase and achieving a cash conversion rate of 82%. This strong cash generation supports ongoing investments and shareholder returns.

Enhanced Shareholder Returns

Tate & Lyle completed a £216 million share buy-back program and increased the full-year dividend by 3.7%, demonstrating a commitment to delivering value to shareholders.

Summarized from source with an LLMView Source

Key figures

-47.3%1Y

-46.8%3Y

-49.3%5Y

Performance

31.1%1Y

24.3%3Y

24.1%5Y

Volatility